BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17475626)

  • 1. A novel binding site for the human insulin-like growth factor-II (IGF-II)/mannose 6-phosphate receptor on IGF-II.
    Delaine C; Alvino CL; McNeil KA; Mulhern TD; Gauguin L; De Meyts P; Jones EY; Brown J; Wallace JC; Forbes BE
    J Biol Chem; 2007 Jun; 282(26):18886-94. PubMed ID: 17475626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.
    Zaccheo OJ; Prince SN; Miller DM; Williams C; Kemp CF; Brown J; Jones EY; Catto LE; Crump MP; Hassan AB
    J Mol Biol; 2006 Jun; 359(2):403-21. PubMed ID: 16631789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational model for the IGF-II/IGF2r complex that is predictive of mutational and surface plasmon resonance data.
    Roche P; Brown J; Denley A; Forbes BE; Wallace JC; Jones EY; Esnouf RM
    Proteins; 2006 Aug; 64(3):758-68. PubMed ID: 16741994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes.
    Brown J; Jones EY; Forbes BE
    Vitam Horm; 2009; 80():699-719. PubMed ID: 19251056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and functional analysis of the IGF-II/IGF2R interaction.
    Brown J; Delaine C; Zaccheo OJ; Siebold C; Gilbert RJ; van Boxel G; Denley A; Wallace JC; Hassan AB; Forbes BE; Jones EY
    EMBO J; 2008 Jan; 27(1):265-76. PubMed ID: 18046459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure.
    Brown J; Jones EY; Forbes BE
    Trends Biochem Sci; 2009 Dec; 34(12):612-9. PubMed ID: 19796953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity.
    Forbe BE; McNeil KA; Scott CD; Surinya KH; Cosgrove LJ; Wallace JC
    Growth Factors; 2001; 19(3):163-73. PubMed ID: 11811790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.
    Rezgui D; Williams C; Savage SA; Prince SN; Zaccheo OJ; Jones EY; Crump MP; Hassan AB
    J Mol Endocrinol; 2009 Apr; 42(4):341-56. PubMed ID: 19208780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.
    Frago S; Nicholls RD; Strickland M; Hughes J; Williams C; Garner L; Surakhy M; Maclean R; Rezgui D; Prince SN; Zaccheo OJ; Ebner D; Sanegre S; Yu S; Buffa FM; Crump MP; Hassan AB
    Proc Natl Acad Sci U S A; 2016 May; 113(20):E2766-75. PubMed ID: 27140600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations.
    Byrd JC; Devi GR; de Souza AT; Jirtle RL; MacDonald RG
    J Biol Chem; 1999 Aug; 274(34):24408-16. PubMed ID: 10446221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor.
    Prince SN; Foulstone EJ; Zaccheo OJ; Williams C; Hassan AB
    Mol Cancer Ther; 2007 Feb; 6(2):607-17. PubMed ID: 17308058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.
    Devi GR; Byrd JC; Slentz DH; MacDonald RG
    Mol Endocrinol; 1998 Nov; 12(11):1661-72. PubMed ID: 9817593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of IGF-II/IGF2R recognition: a combined molecular dynamics simulation, free-energy calculation and computational alanine scanning study.
    Guo J; Wang X; Sun H; Liu H; Yao X
    J Mol Model; 2012 Apr; 18(4):1421-30. PubMed ID: 21761181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-2 IGF receptor: a multi-ligand binding protein.
    Braulke T
    Horm Metab Res; 1999; 31(2-3):242-6. PubMed ID: 10226808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11.
    Williams C; Rezgui D; Prince SN; Zaccheo OJ; Foulstone EJ; Forbes BE; Norton RS; Crosby J; Hassan AB; Crump MP
    Structure; 2007 Sep; 15(9):1065-78. PubMed ID: 17850746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
    Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
    J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Takifugu rubripes cation independent mannose 6-phosphate receptor: Cloning, expression and functional characterization of the IGF-II binding domain.
    A AK; Nadimpalli SK
    Int J Biol Macromol; 2018 Jul; 113():59-65. PubMed ID: 29408008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the insulin-like growth factor II binding site to amino acids 1508-1566 in repeat 11 of the mannose 6-phosphate/insulin-like growth factor II receptor.
    Schmidt B; Kiecke-Siemsen C; Waheed A; Braulke T; von Figura K
    J Biol Chem; 1995 Jun; 270(25):14975-82. PubMed ID: 7797478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
    Zavorka ME; Connelly CM; Grosely R; MacDonald RG
    Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.